Detail akcie AptarGroup Inc online

Business Summary: AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, AptarGroup, Inc. revenues increased 5% to $3.49B. Net income increased 19% to $284.5M. Revenues reflect Aptar Pharma segment increase of 12% to $1.52B, Aptar Beauty segment increase of 4% to $1.27B, France segment increase of 15% to $1.08B, Germany segment increase of 10% to $564.5M. Net income benefited from Miscellaneous, net increase from $4.8M (expense) to $3.2M (income).